| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1148 | 15 | 783 | 77 | 937 | 164 | 998 |
| ERLYTX | 73 | 0 | 0 | 3 | 37 | 7 | 43 |
| GI | 164 | 3 | 157 | 15 | 183 | 29 | 177 |
| GU | 395 | 9 | 470 | 45 | 548 | 91 | 554 |
| LEUK | 160 | 2 | 104 | 13 | 158 | 27 | 164 |
| LUNG | 205 | 2 | 104 | 11 | 134 | 22 | 134 |
| LYMPH | 423 | 8 | 417 | 29 | 353 | 66 | 402 |
| MELAN | 8 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 115 | 2 | 104 | 15 | 183 | 21 | 128 |
| MULT | 50 | 1 | 52 | 2 | 24 | 3 | 18 |
| OTHER | 43 | 0 | 0 | 1 | 12 | 2 | 12 |
| Total | 2784 | 42 | 2191 | 212 | 2581 | 433 | 2636 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 211 | 3 | 157 | 16 | 195 | 36 | 219 |
| ERLYTX | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| GI | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| GU | 5 | 0 | 0 | 1 | 12 | 3 | 18 |
| LEUK | 611 | 8 | 417 | 50 | 609 | 103 | 627 |
| LUNG | 369 | 10 | 522 | 41 | 499 | 65 | 396 |
| LYMPH | 1 | 1 | 52 | 1 | 12 | 1 | 6 |
| OTHER | 15 | 0 | 0 | 0 | 0 | 4 | 24 |
| PEOLC | 65 | 0 | 0 | 3 | 37 | 3 | 18 |
| PREV | 229 | 0 | 0 | 18 | 219 | 25 | 152 |
| SXQOL | 653 | 7 | 365 | 46 | 560 | 98 | 597 |
| Total | 2162 | 29 | 1513 | 176 | 2143 | 338 | 2057 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1148 | 15 | 783 | 77 | 937 | 164 | 998 |
| CCD | 211 | 3 | 157 | 16 | 195 | 36 | 219 |
| ERLYTX | 75 | 0 | 0 | 3 | 37 | 7 | 43 |
| GI | 165 | 3 | 157 | 15 | 183 | 29 | 177 |
| GU | 400 | 9 | 470 | 46 | 560 | 94 | 572 |
| LEUK | 771 | 10 | 522 | 63 | 767 | 130 | 791 |
| LUNG | 574 | 12 | 626 | 52 | 633 | 87 | 530 |
| LYMPH | 424 | 9 | 470 | 30 | 365 | 67 | 408 |
| MELAN | 8 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 115 | 2 | 104 | 15 | 183 | 21 | 128 |
| MULT | 50 | 1 | 52 | 2 | 24 | 3 | 18 |
| OTHER | 58 | 0 | 0 | 1 | 12 | 6 | 37 |
| PEOLC | 65 | 0 | 0 | 3 | 37 | 3 | 18 |
| PREV | 229 | 0 | 0 | 18 | 219 | 25 | 152 |
| SXQOL | 653 | 7 | 365 | 46 | 560 | 98 | 597 |
| Total | 4946 | 71 | 3706 | 388 | 4724 | 771 | 4694 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 703 | 11 | 574 | 45 | 548 | 90 | 548 |
| ERLYTX | 53 | 0 | 0 | 3 | 37 | 5 | 30 |
| GI | 125 | 1 | 52 | 9 | 110 | 22 | 134 |
| GU | 291 | 5 | 261 | 29 | 353 | 60 | 365 |
| LEUK | 98 | 0 | 0 | 6 | 73 | 12 | 73 |
| LUNG | 130 | 2 | 104 | 6 | 73 | 16 | 97 |
| LYMPH | 276 | 7 | 365 | 17 | 207 | 44 | 268 |
| MELAN | 8 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 65 | 2 | 104 | 11 | 134 | 12 | 73 |
| MULT | 20 | 1 | 52 | 2 | 24 | 2 | 12 |
| OTHER | 43 | 0 | 0 | 1 | 12 | 2 | 12 |
| Total | 1812 | 29 | 1512 | 130 | 1583 | 266 | 1618 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 155 | 1 | 52 | 10 | 122 | 25 | 152 |
| ERLYTX | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| GI | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| GU | 5 | 0 | 0 | 1 | 12 | 3 | 18 |
| LEUK | 249 | 4 | 209 | 19 | 231 | 34 | 207 |
| LUNG | 226 | 7 | 365 | 27 | 329 | 43 | 262 |
| LYMPH | 1 | 1 | 52 | 1 | 12 | 1 | 6 |
| OTHER | 15 | 0 | 0 | 0 | 0 | 4 | 24 |
| PEOLC | 54 | 0 | 0 | 3 | 37 | 3 | 18 |
| PREV | 229 | 0 | 0 | 18 | 219 | 25 | 152 |
| SXQOL | 475 | 4 | 209 | 33 | 402 | 72 | 438 |
| Total | 1412 | 17 | 887 | 112 | 1364 | 210 | 1277 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 900 | 15 | 783 | 62 | 755 | 135 | 822 |
| CCD | 171 | 1 | 52 | 7 | 85 | 21 | 128 |
| ERLYTX | 55 | 0 | 0 | 3 | 37 | 5 | 30 |
| GI | 139 | 1 | 52 | 10 | 122 | 28 | 170 |
| GU | 329 | 5 | 261 | 32 | 390 | 67 | 408 |
| LEUK | 350 | 4 | 209 | 25 | 304 | 46 | 280 |
| LUNG | 386 | 10 | 522 | 35 | 426 | 66 | 402 |
| LYMPH | 277 | 8 | 417 | 18 | 219 | 45 | 274 |
| MELAN | 8 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 65 | 2 | 104 | 11 | 134 | 12 | 73 |
| MULT | 42 | 0 | 0 | 4 | 49 | 10 | 61 |
| OTHER | 123 | 0 | 0 | 1 | 12 | 6 | 37 |
| PEOLC | 55 | 0 | 0 | 3 | 37 | 3 | 18 |
| PREV | 229 | 0 | 0 | 18 | 219 | 25 | 152 |
| SXQOL | 475 | 4 | 209 | 33 | 402 | 72 | 438 |
| Total | 3604 | 50 | 2609 | 263 | 3203 | 542 | 3299 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 990 | 15 | 783 | 73 | 889 | 154 | 937 |
| ERLYTX | 69 | 0 | 0 | 3 | 37 | 7 | 43 |
| GI | 97 | 1 | 52 | 11 | 134 | 19 | 116 |
| GU | 285 | 8 | 417 | 36 | 438 | 66 | 402 |
| LEUK | 131 | 2 | 104 | 12 | 146 | 24 | 146 |
| LUNG | 181 | 2 | 104 | 11 | 134 | 21 | 128 |
| LYMPH | 350 | 8 | 417 | 28 | 341 | 57 | 347 |
| MMYEL | 102 | 2 | 104 | 14 | 170 | 20 | 122 |
| MULT | 50 | 1 | 52 | 2 | 24 | 3 | 18 |
| Total | 2255 | 39 | 2033 | 190 | 2313 | 371 | 2259 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1888 | 30 | 1565 | 141 | 1717 | 279 | 1698 |
| AFFIL | 125 | 0 | 0 | 3 | 37 | 7 | 43 |
| CCOP/NCORP | 1211 | 16 | 835 | 98 | 1193 | 190 | 1157 |
| Non-SWOG | 1719 | 22 | 1148 | 143 | 1741 | 292 | 1778 |
| Total | 4943 | 68 | 3548 | 385 | 4688 | 768 | 4676 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| LEUK | S2507 | ALL/ALAL, KMT2A-trans, Blina +/- Revumenib | 1 | Y | 22-SEP-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| OTHER | NRGGY026 | Endomet, Stage I-IV, Pac/Car w/ HER HYL/PHE | 1 | E | 29-SEP-26 |
| OTHER | NRGBN003 | Mening, Grd II, Observation vs Irradiation | 1 | E | 28-SEP-26 |
| OTHER | NRGBN003 | Mening, Grd II, Observation vs Irradiation | 2 | E | 28-SEP-26 |
| SXQOL | NRG-CC013 | HN Squamous Cell, Rec Chemo, BMX | 1 | E | 23-SEP-26 |
| OTHER | NRGHN009 | HN, RT + HD Cisp vs RT + LD Cisp for SCCHN | 1 | E | 02-OCT-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 14 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 10 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 9 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 8 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 6 |
| LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 6 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 5 |
| GU | S2427 | Blad, MIBC, RT + Pembrolizumab | 1 | 4 |
| CCD | S2417CD | Colrec Surv, Follow-up w/ CTAC site | 1 | 3 |